While the ‘official’ flu season may still be a month or two away, reports indicate a rise in respiratory illnesses like the ...

Pfizer’s RSV vaccine Abrysvo receives European approval to help protect adults aged 18-59 against RSV lower respiratory tract disease: New York Wednesday, April 2, 2025, 09:00 H ...

CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. today announced that the Australian Therapeutic Goods Administration (TGA) has granted approval for mRESVIA® (mRNA-1345), an mRNA ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...

Pfizer’s respiratory syncytial virus (RSV) vaccine has been approved by the European Commission (EC) to prevent RSV-associated lower respiratory tract disease (LRTD) in individuals aged 18 to 59 years ...

The authors assessed the patient characteristics associated with RSV vaccination among older adults hospitalized during the ...

The resignation of one of the FDA's top officials, Peter Marks, is worrying Wall Street as they await a replacement.

However, in the later stages of the pandemic, demand for the product declined, and Moderna shifted to a loss. For example, ...

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...

Planet Classroom, the global youth-driven media network, unveils an extraordinary selection of films for April 2025, featuring trailblazing innovations in AI, climate action, classical music, and ...

AbbVie, Thermo Fisher Scientific, and Moderna are the three Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks represent shares of companies that focus on ...